Evidence map›Paper›PMID 36741983›Full record

ReviewIJID regions2023

Expectations and disappointments relative to COVID-19 passes: results from a voluntary mixed-methods study in French-speaking Belgium.

Nicolas Vermeulen, Morgane Guyomarch, Boris Jidovtseff, Amandine Oleffe, Aline Labat, Elisabeth Paul

Abstract readReview
In one paragraph

Review in IJID regions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicolas VermeulenUniversité catholique de Louvain, Psychological Sciences Research Institute (IPSY), Louvain-la-Neuve, Belgium.
Morgane GuyomarchUniversité libre de Bruxelles, School of Public Health, Brussels, Belgium.
Boris JidovtseffUniversité de Liège, Research Unit for a Life-Course Perspective on Health and Education, Liège, Belgium.
Amandine OleffeUniversité libre de Bruxelles, School of Public Health, Brussels, Belgium.
Aline LabatUniversité libre de Bruxelles, School of Public Health, Brussels, Belgium.
Elisabeth PaulUniversité libre de Bruxelles, School of Public Health, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Belgium enacted a coronavirus disease 2019 (COVID-19) pass - the 'COVID Safe Ticket' (CST) - in October 2021. This study aimed to understand the expectations and reasons given by those supporting this policy measure. Methods: This mixed methods study was based on a voluntary online survey among 9444 French-speaking residents in Belgium. Results: Most respondents were not very supportive of the CST, with only 617 respondents (7%) being pro-CST. Compared with other respondents, the pro-CST sample comprised more males, older people, people scared of COVID-19, people who had confidence in the COVID-19 vaccines, and highly educated people. A qualitative analysis was undertaken to identify the reasons why respondents supported the CST. Two lines of argument were related to personal comfort (individual protection and means of 'recovering freedom'), and two other lines were related to collective protection (controlling the pandemic and incentivizing vaccination). Pro-CST respondents also indicated some limitations of the CST. Conclusions: The expectations regarding the CST were high, diverse and not entirely rational. Some contradictions and frustration emerged from the respondents' comments. The CST may have exacerbated the social divide in society. The high expectations risk leading to comparably high levels of disappointment, resulting in potential distrust towards future public health interventions.

Indexed as

BelgiumCOVID-19COVID-19, Coronavirus disease 2019COVID passCST, COVID Safe TicketPCR, Polymerase Chain ReactionPublic Health PolicyTerror Management TheroyTMT, Terror Management TheoryVaccines

Identifiers

PMID36741983
PMCPMC9884140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.